Posts

NCPL 🎰 This is Skillful Gambling Territory

NCPL (Netcapital Inc.): High Borrow Costs, Low-Float Dynamics, and What Similar Setups Have Shown Historically NCPL (Netcapital Inc.): High Borrow Costs, Low-Float Dynamics, and What Similar Setups Have Shown Historically Data as of midday June 26, 2026. This is an analytical overview for educational and research purposes only. Current Snapshot NCPL is a microcap fintech stock (NASDAQ: NCPL) trading around the 0.55 area after a +5.7% intraday move on roughly 558k shares of volume. The day’s range has been approximately 0.51 – 0.60 . Key stats include: Market cap: ≈ $4.3M Shares outstanding: ≈ 7.85M Free float: ≈ 4.4M shares 52-week range: 0.3115 – 8.75 Average volume (3M): ≈ 3.7M shares EPS (TTM): –11.41 Book value per share: ≈ 3.155 (trading at roughly 0.17x book) Warrants (NCPLW) have traded near 0.0266 . TradingView chart: NASDAQ:NCPL ...
Post a Comment
Read more

In Limbo — Just How Low Can You Go Zillow?

Zillow (Z) Stock Analysis: Trading Near 52-Week Low – Is It a Buying Opportunity? Zillow Group (Z) Stock Analysis: Near 52-Week Low – Potential Entry Points, Scenarios & Turnaround Outlook (June 2026) Posted on [Insert Date] Zillow Group (NASDAQ: Z / ZG ) has plummeted over 50% year-to-date and is trading near its 52-week low around $29–$30 as of late June 2026. The stock reached as low as $29.23 in recent sessions, far below its 52-week high near $93.88. [](grok_render_citation_card_json={"cardIds":["488ba4","68b894"]}) Despite the sell-off, the company's financials show resilience with solid revenue growth and improving profitability. Is this a deep-value opportunity in online real estate, or are ongoing risks (competition from Google, legal issues) too high? Here's a detailed breakdown. Quick Price Snapshot (as of late June 2026) Recent Price: ~$29.40 – $30.50 range 52-Week Range: $29.23 – $93....
Post a Comment
Read more

Why Aren't You Rich?

The Invisible Tax: Why Financial Skill Doesn’t Always Equal a Fat Bank Account A perspective on execution, systemic headwinds, and the unseen battles behind the numbers. "To be Rich, I would have to change my name" We live in a culture obsessed with a very simplistic equation: If you’re smart and skilled, you should be rich. If you aren’t rich, you must not be trying hard enough. It’s a neat, comfortable lie. It allows people to look at someone’s bank balance and instantly pass judgment on their capabilities, their intelligence, and their work ethic. But out here in the real world, that equation is completely broken. You can have elite-level skills—whether in trading, coding, or any other high-stakes discipline—and still find yourself fighting tooth and nail against economic gravity. People see the struggle, but they are entirely blind to the warfare happening behind the scenes. They see the...
Post a Comment
Read more

Water We Going To Do About It?

Image
Investing in Water: Turning Scarcity into a Long-Term Macro Play The image above captures a familiar moment for many traders: a clean Instagram graphic titled “INVEST IN WATER” and a text message asking, “Can you check this out and see if it's worth it?” The graphic breaks the water theme into categories like Water Utilities , Water Tech & Solutions , and Water Infrastructure & Treatment . In the conversation, Badger Meter (BMI) and Valmont Industries (VMI) get called “expensive”—and they often are. Both trade at premium valuations because they operate in critical, hard-to-replace niches. If you like the water scarcity thesis but don’t want to overpay, here’s how to build a smarter, diversified playbook around the theme. 1. Direct Equity Plays: Beyond Just BMI and VMI Water Tech & Infrastructure Xylem (XYL): A global leader in water technology covering the entire water ...
Post a Comment
Read more

TKO Which Way You Gonna Go?

TKO: Constructive Test of Resistance on Light Volume (June 24, 2026) TKO: Constructive Test of Resistance on Light Volume (June 24, 2026) Posted: June 24, 2026 I’ve been watching TKO (TKO Group Holdings — the UFC/WWE parent) today and it’s a clean example of something I see fairly often in swing setups: price making a decent push into resistance while volume stays conspicuously quiet. Today’s Numbers (as of \~2:00 PM CDT) Previous close: 202.70 Open: \~203.52–203.58 Day high: 206.75 Current price: \~205.4–205.7 (+1.3–1.4%) Volume: \~350K–540K vs \~1.5–2.0M average That’s roughly 25–35% of normal daily volume. The stock is holding above the open, tagging the upper end of the day’s range, and putting in a solid green day. On the surface it looks constructive. What Stands Out Bullish Trading well above the open Making a higher high and holding near session highs Positive momentum (+1.3%+) Sitting right at the lower edge of the resista...
Post a Comment
Read more

OUCH Grok API

💡 Is the Grok API Worth It? The Grok API can be incredibly powerful, and you can get a tremendous amount of work done in a very short period of time. It's honestly hard to argue that it isn't worth the cost. That said, I've learned that sloppy prompting costs extra tokens . Here are a few simple ways to reduce token usage: Use shorter, more direct prompts. Skip unnecessary words like "please" and "thank you." Avoid running the same report repeatedly. Build in fail-safes to prevent duplicate requests. Be intentional and efficient with your prompts. A little optimization can save you a surprising number of tokens over time. Overall, if you're smart about how you use it, the Grok API can be an excellent value and a huge productivity booster. ☕ Support My Work If you find this content valuable and it has saved you time or money, please consider supporting me on Ko-fi. Every contribution helps me continue creating useful cont...
Post a Comment
Read more

Stock explodes! Here's why!

Why the News Always Seems Late to the Market One of the observations that repeatedly changed the way I look at markets was noticing how often stocks moved before any explanation appeared. A stock would break out on heavy volume, a sector would suddenly catch a bid, or a major index would reverse sharply, yet there would be no obvious headline explaining the move. Hours later, the financial media would publish a story assigning a reason to the price action. The explanation might sound convincing, but the timing often raises an important question: was the news driving the move, or was the news simply explaining a move that had already happened? The Anatomy of the Lagging Narrative Every active trader has experienced the comedy of watching a clean technical breakout or breakdown trigger perfectly on price, volume, and order flow, only for the financial media to remain completely silent. Then, two hours later, the "breaking news" alert drops to retroactively assign a n...
Post a Comment
Read more

AXTI — Oops old article didn't publish in the right place

AXTI Swing Trading Playbook - May 28, 2026 Current Price Range ~$115 – $117 ▲ Volatile Previous Close $115.70 Assessment Date May 28, 2026 AXT Inc. (AXTI) is a specialty materials company that manufactures compound semiconductor substrates, primarily indium phosphide (InP), gallium arsenide (GaAs), and germanium wafers. These materials are essential for high-growth sectors including AI data centers, 5G/6G infrastructure, optical networking, LEDs, and solar cells. The company is aggressively expanding InP production capacity to capitalize on surging AI demand. Swing Trade Scenarios & Risk Profiles Scenario Entry Point Stop-Loss Target(s) Potential Return R:R Ratio Est. Prob. Strategic Notes Bullish Pullback Buy...
Post a Comment
Read more

PIII Technical Swing Trade: Oversold Bounce Setup Emerges at Key Support

PIII Technical Swing Trade: Oversold Bounce Setup Emerges at Key Support PIII Technical Swing Trade: Oversold Bounce Setup Emerges at Key Support Published: June 23, 2026 • Personal Trading Playbook 48/100 Conviction Score 1:2.6 Risk / Reward +47.0% Expected Value 1–2% Suggested Alloc. AI Execution Summary: P3 Health Partners (PIII) reported a strong Q1 2026 turnaround with $25.8 million adjusted EBITDA and raised full-year guidance to $20-60 million EBITDA on $1.5-1.65 billion revenue, shifting from prior losses to profitability signals in its Medicare Advantage value-based care model. Combined with the stock's sharp pullback to the $10.75 area on June 18, 2026, and RSI nearing oversold levels around 33, this creates a compelling technical swing setup for a bounce toward $11.80 and $14.00 analyst targets. The physician-led population health platform posi...
Post a Comment
Read more

NRDS Swing Setup: Neutral RSI at $8.59 Creates Measured Long Opportunity with Strong Asymmetry

NRDS Swing Setup: Neutral RSI at $8.59 Creates Measured Long Opportunity with Strong Asymmetry NRDS Swing Setup: Neutral RSI at $8.59 Creates Measured Long Opportunity with Strong Asymmetry Published: June 23, 2026 • Personal Trading Playbook 61/100 Conviction Score 1:4.3 Risk / Reward +10.4% Expected Value 2–3% Suggested Alloc. AI Execution Summary: NRDS presents a moderate-conviction long swing setup with an attractive asymmetric risk-to-reward edge of 1:4.3. Price action has stabilized just above the critical $8.20-8.34 support shelf while RSI remains neutral near 51, suggesting room for upside without immediate overbought conditions. Timing is favorable with the stock trading only 0.5-1.6% above the planned structural entry zone of $8.45-8.55 on June 22, 2026, allowing for a disciplined reload on any minor dip. The setup is supported by analyst price targ...
Post a Comment
Read more

QH Stock: High-Volume Momentum Breakout Sets Up Aggressive Swing Long Opportunity

QH Stock: High-Volume Momentum Breakout Sets Up Aggressive Swing Long Opportunity QH Stock: High-Volume Momentum Breakout Sets Up Aggressive Swing Long Opportunity Published: June 23, 2026 • Personal Trading Playbook 33/100 Conviction Score 1:1.5 Risk / Reward +32.3% Expected Value 0–0.5% Suggested Alloc. AI Execution Summary: QH presents a cautious-conviction speculative profile with an asymmetric but low-probability risk-to-reward edge of roughly 1:1.8. Price has broken sharply below key short-term EMAs on heavy volume with RSI at approximately 37.6, signaling weakening momentum in a strong downtrend. Timing is poor as the live price sits well below the planned entry zone near $8.00-8.50, offering no immediate structural reload opportunity without further stabilization or catalyst-driven reversal. Trade Execution Matrix ...
Post a Comment
Read more

ACHV Swing Trade Setup: Late-Stage Pipeline Centered on Cytisinicline for Nicotine Dependence

ACHV Swing Trade Setup: Post-Breakdown Reversal Opportunity or Wait-and-See? ACHV Swing Trade Setup: Post-Breakdown Reversal Opportunity or Wait-and-See? Published: June 23, 2026 • Personal Trading Playbook 59/100 Conviction Score 1:1.2 Risk / Reward +11.8% Expected Value 2–3% Suggested Alloc. AI Execution Summary: ACHV presents a moderate-conviction technical swing setup with an asymmetric risk-to-reward edge of 1:1.8. Price action has rebounded sharply from oversold RSI levels on elevated volume following the June 20, 2026 PDUFA outcome, with the stock trading just 0-2% above the planned structural entry zone near $5.00-5.10 as of June 23, 2026. The key catalyst remains the company's plan to address the FDA's manufacturing-related Complete Response Letter with a targeted Q4 resubmission, positioning cytisinicline for potential approval as the first ...
Post a Comment
Read more

Sector Rotation Biotech Up

How This Ended Up On My Radar I wasn't actively looking for a biotech rotation. What caught my attention was something much simpler: several healthcare and biotech names on my watchlists were holding up surprisingly well while many technology names were seeing profit taking. When individual stocks start acting differently than the broader market, I pay attention. A few isolated names can be random. Multiple names showing relative strength at the same time often signals something larger happening beneath the surface. After seeing repeated strength across several healthcare and biotech setups, I started digging deeper. That's when the pieces began lining up: institutional money rotating out of crowded technology trades, a major biotech acquisition, a successful IPO, and improving action across the broader group. The sector didn't become interesting because of a headline. The headlines helped explain what the charts were already starting to show. The market just handed u...
Post a Comment
Read more